Skip to main content

Perspectives in Lung Cancer Care: Targeted Therapies 101

The presentations in this on-demand event include the following (You will have to create an account to view): 

Best Practices for Molecular Testing in Advanced NSCLC and Decoding NGS Reports

How much do you know about optimal molecular testing methods for patients with advanced NSCLC?
Dara L. Aisner, MD, PhD

What Do We Do When Osimertinib Stops Working for Classic EGFR Mutations?

Do you know how to best manage your patients with mNSCLC and EGFR mutations that progress after osimertinib?
Helena Yu, MD

Tips and Tricks for Management of TKI-Related Toxicities

Learn optimal management strategies for TKI-related toxicities.
Tara Plues, CNP

View presentations here.